Flash Sell! Take a Fast Profit on This Highflier!

By Ray BlancoPosted November 23, 2020

I am writing to you early this week to take advantage of a quick action on a recent play. Furthermore, with the possibility that some of you might be traveling Wednesday for the Thanksgiving holiday, I don’t want you to miss out on a quick profit.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Ray Blanco’s FDA Profit Alert

The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Buy These 3 Stocks Right Now to Make 50% in 12 Months

By Paul MampillyPosted August 20, 2014

And when I mean buy, I really mean buy. That's why this week I want you to buy not one. Not two. But three stocks. Whoa! Three stocks, all at once? What's going on? Is that what you are thinking? Yes, three stocks. I want you to buy three stocks all at once right now. Why? You know why? A tiger stalking its prey…

Flash Sell! Sell Shares at This Catalyst Event

By Ray BlancoPosted May 7, 2019

Biotech news flow is heating up as companies issue quarterly reports. And, with several catalysts now passed, we take action on one of our latest trades.

This Chart Shows We’re on the Right Track for Big Gains

By Ray BlancoPosted May 24, 2017

Our first new recommendation for the year has been a slow but steady gainer. Shares are up just under 10% since I brought it to your attention in January. It's important to note, however, that shares are moving along nicely in an upward trend. Here’s why we think that is likely to continue…

Flash Alert: Jump On This Discounted Biotech Now

By Ray BlancoPosted March 18, 2020

The coronavirus-induced selling in the markets is exposing great opportunities in the biotech space. Today I’m going to tell you about a cell therapy company that’s in the final stage before an FDA decision, with a platform that might prove to be useful in treating coronavirus itself.

Flash Buy! Big Potential from This China-Centric Drug Developer

By Ray BlancoPosted February 10, 2021

Today’s American biotech has been a big player in the Chinese market. In fact, it was the first U.S. biotech to receive a new drug approval in China before the United States. But now it’s the FDA’s turn to review the company’s drug, roxadustat, for the treatment of anemia in patients with chronic kidney disease. Strong clinical data makes the likelihood of approval very good.

Flash Buy! Don’t Miss out on Gains From This Emerging Cancer Powerhouse!

By Ray BlancoPosted May 13, 2015

We're now in the midst of a complete revamp of how we deal with cancer. Cancer is the No. 2 killer in the U.S. New and better cancer therapies that train your body to heal itself are going to lengthen life spans... and fatten wallets.

Login